Pāriet uz galveno navigāciju Pāriet uz meklēšanu Pāriet uz galveno saturu

A nonsynonymous variant I248L of the adenosine A3 receptor is associated with coronary heart disease in a latvian population

  • Latvian Institute of Organic Synthesis
  • Paula Stradina Clinical University Hospital

Zinātniskās darbības rezultāts: Devums žurnālamZinātniskais raksts (žurnālā)koleģiāli recenzēts

9 Atsauces (Scopus)

Kopsavilkums

Adenosine plays an important part in the cardiac response to ischemia and reperfusion. The human adenosine receptor A3 (A 3R), along with other adenosine receptors, is involved in mediation of those effects. The aim of the study was to ascertain whether the nonsynonymous single-nucleotide polymorphism (SNP) I248L (reference SNP ID: rs35511654) located in the A 3R gene is associated with coronary heart disease (CHD). DNA samples from 683 individuals with CHD and from 826 control subjects selected from the Latvian Genome Database were successfully screened for rs35511654 using the TaqMan SNP Genotyping Assay. We observed a significantly decreased frequency of the rs35511654 C allele in a group of CHD patients compared with that in controls (p=0.009). The association remained significant after adjustment for age, sex, and other nongenetic factors (p=0.02). These results suggest that A allele of rs35511654 may predispose to CHD.

OriģinālvalodaAngļu
Lapas (no-līdz)907-911
Lapu skaits5
ŽurnālsDNA and Cell Biology
Sējums30
Izdevuma numurs11
DOIs
Publikācijas statussPublicēts - 1 nov. 2011

ANO IAM

Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)

  1. 3. IAM — Laba Veselība un Labbūtība
    3. IAM — Laba Veselība un Labbūtība

Nospiedums

Uzziniet vairāk par pētniecības tēmām “A nonsynonymous variant I248L of the adenosine A3 receptor is associated with coronary heart disease in a latvian population”. Kopā tie veido unikālu nospiedumu.

Citēt šo